Gsk (GSK) Change in Intangibles (2009 - 2026)

Gsk's Change in Intangibles history runs 18 years deep, the most recent figure standing at $393.1 million for Q2 2026.

• In Q2 2026, Change in Intangibles rose 178.16% year-over-year to $393.1 million; the TTM figure through Jun 2026 stood at $626.4 million (up 356.77% YoY), while the FY2025 annual figure was $151.6 million, down 9.45% from the prior year.
• Change in Intangibles for Q2 2026 stood at $393.1 million, up from $83.6 million in the prior quarter.
• The five-year high for Change in Intangibles was $393.1 million in Q2 2026, with the low at -$502.9 million in Q2 2025.
• The 5-year median for Change in Intangibles is $34.2 million (2024), against an average of $3.5 million.
• The sharpest annual moves came in 2024 and 2025: Change in Intangibles surged 604.44% in 2024, then slumped 39945.27% in 2025.
• Gsk's Change in Intangibles stood at $15.2 million in 2022, then tumbled by 1744.82% to -$250.8 million in 2023, then soared by 114.33% to $35.9 million in 2024, then jumped by 181.3% to $101.1 million in 2025, then jumped by 288.86% to $393.1 million in 2026.
• Business Quant data shows GSK's Change in Intangibles at $393.1 million in Q2 2026, $83.6 million in Q1 2026, and $101.1 million in Q4 2025.